Skip to content
Review Open access

A Systematic Review and Meta-Analysis of the Prevalence and Antibiotic Resistance Patterns of Campylobacter Species in Low- and Middle-Income Countries: A One-Health Perspective

Nov 2026 · Environmental Health Insights · 0 citations · 134 references

Abstract

Campylobacter infections are increasing globally, with an estimated 400-500 million cases recorded annually. Low- and middle-income countries (LMICs) conditions facilitate the transmission of these pathogens between humans and animals, contributing to the global increase in infections. This systematic review and meta-analysis assessed the prevalence and antimicrobial resistance patterns of Campylobacter species in LMICs from the One-Health perspective. Comprehensive literature searches were conducted in PubMed, SCOPUS, and Web of Science. A total of 530 retrieved articles were screened using a predefined selection criterion. Prevalence and resistance meta-analyses were conducted by subjecting the extracted data to the random-effects model in RStudio version 4.4.2. Meta-regression and sensitivity analysis were conducted to assess the moderators of heterogeneity and robustness of included studies, respectively. A total of 130 articles were included in this study. The prevalence of Campylobacter species was highest in animals (14.76% [12.44; 17.25]), followed by the environment (10.95% [6.93; 16.47]) and humans (10.34% [7.41; 13.68]). The most prevalent species were C. jejuni , C. coli , and C. upsaliensis in all three sample sources. Lower-middle-income economies had the highest prevalence, followed by upper-middle-income economies and low-income economies. Generally, all Campylobacter spp. showed high resistance to tetracycline (66.82% [62.10; 71.40]), nalidixic acid (65.18% [59.12; 71.03]), and ciprofloxacin (62.52% [57.20; 67.71]). Additionally, there was a 60.65% [53.78; 67.32] prevalence of multidrug resistance (MDR), followed by extensive drug resistance (XDR) with 55.14% [29.74; 79.21] and pan-drug resistance (PDR) with 1.68% [0.57; 3.23]. There is a higher prevalence of Campylobacter species in animals compared to humans and the environment in LMICs, coupled with a high prevalence of multidrug resistance. Hence, stricter monitoring and regulation of antibiotic use in animal farming and humans are required to curb the increasing antibiotic resistance.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.